Rein Therapeutics Inc (RNTX)

Rein Therapeutics Inc (RNTX) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $54.2M; returns 1 day -3.4%, 1 week -1.4%, 1 year -53.8%.

Rein Therapeutics, Inc. (RNTX) is a clinical-stage biotechnology company primarily focused on the development of novel therapies for severe lung diseases. The company is currently pre-revenue, with its business model centered around advancing its lead product candidate, LTI-03, through clinical trials.

Groups RNTX belongs to

• Clinical Stage Biotech
• Biotechnology
• Healthcare
• Fibrosis
• Life Sciences
• Clinical Stage
• Rare Diseases
• R&D

RNTX financial model: income statement, cash flow and balance sheet